HeartBeam launches pilot study of on-demand 12-lead ECG patch for ischemia detection
HeartBeam
HeartBeam BEAT | 0.00 |
- HeartBeam launched pilot study of investigational on-demand 12-lead ECG patch in patients with suspected coronary artery disease.
- Results have not been presented; study will compare patch-generated readings with standard 12-lead ECGs taken at same time during exercise stress testing to assess whether device can detect ischemia outside clinic.
- Program targets ambulatory patch monitoring market estimated at $2 billion, where most current devices focus on rhythm assessment rather than ischemia detection.
- Trial plans enrollment of about 50 patients at two hospitals in Belgrade, Serbia, with findings expected to inform regulatory strategy for patch.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartbeam Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605110831BIZWIRE_USPR_____20260511_BW267980) on May 11, 2026, and is solely responsible for the information contained therein.
